These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 28802)

  • 1. [Status of T- and B-lymphocytes in long living CBA--F1 (CBA X C57BL/6) chimeras].
    Cherniakhovskaia IIu; Nesterenko VG; Filitis LN; Fontalin LN; Novikova TK
    Biull Eksp Biol Med; 1978 Aug; 86(8):197-200. PubMed ID: 28802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specific reactivity of semi-allogeneic chimeras produced using cyclophosphamide].
    Nagurskaia EV; Cherniakhovskaia IIu
    Biull Eksp Biol Med; 1987 Sep; 104(9):334-7. PubMed ID: 2959332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of subclinical level of graft versus host reaction on reconstitution of host lymphoid tissues].
    Hirano M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):453-65. PubMed ID: 7927174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune competence of splenic lymphocytes following graft-vs-host disease in mouse allogeneic radiation chimeras.
    Urso P; Gengozian N
    J Immunol; 1977 Feb; 118(2):657-61. PubMed ID: 14214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV; Chernyakhovskaya IJ; Fontalin LN
    Folia Biol (Praha); 1984; 30(4):209-20. PubMed ID: 6383881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens.
    Miconnet I; Bruley-Rosset M; Halle-Pannenko O
    J Immunol; 1992 Jun; 148(12):3706-13. PubMed ID: 1534822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of proliferative responses to host Ia antigens in fully allogeneic bone marrow chimeras in mice--sequential analysis of the reactivity and characterization of the cells involved in the response].
    Iwabuchi K
    Hokkaido Igaku Zasshi; 1986 Nov; 61(6):869-82. PubMed ID: 3493963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between T- and B-lymphocyte cooperation and their syngeneity].
    Fontalin LN; Novikova TK; Pevnitskiĭ LA; Kondrat'eva IA
    Biull Eksp Biol Med; 1976 Mar; 81(3):325-7. PubMed ID: 1085176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
    Norin AJ; Emeson EE; Veith FJ
    J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft disease.
    Hard RC; Carter WH; Bick PH
    J Immunol; 1983 Dec; 131(6):2623-9. PubMed ID: 6358351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.
    Shand FL
    Immunology; 1975 Dec; 29(6):953-65. PubMed ID: 325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.